Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Cambrex announced that it has completed the construction of a $24 million highly potent API (HPAPI) manufacturing facility at its site in Charles City, IA.
read more
Catalent and Paragon Bioservices announced they have entered into a definitive agreement under which Catalent will acquire Paragon for $1.2 billion.
read more
Hovione Technology has secured global rights to develop and commercialize a new ultra-affordable, multi-use blister-based dry powder inhaler patented by inventor Dr. Klaus-Dieter Beller.
read more
Fujifilm Diosynth Biotechnologies has announced the reduction of cell line development timelines with its Apollo X™ Advanced Mammalian Expression System.
read more
Wednesday, April 17, 2019
Greenfield Global has announced plans to establish a new EU manufacturing headquarters in Portlaoise, Ireland.
read more
Wednesday, April 17, 2019
PerkinElmer announced it has joined Accenture’s open partner ecosystem, designed to help solution providers, software vendors and life sciences companies accelerate drug discovery.
read more
Wednesday, April 17, 2019
Seven Bridges has announced the availability of the Seven Bridges Automation Tools and Services.
read more
Wednesday, April 17, 2019
Encube Ethicals has announced its new high potency manufacturing facility for topical formulations is now fully operational.
read more
Wednesday, April 17, 2019
Veeva Systems announced a top 20 pharmaceutical company has selected Veeva Vault Clinical Data Management System (CDMS) as their global standard for EDC, coding, data cleaning, and reporting.
read more
Wednesday, April 17, 2019
Fibrocell announced a collaboration agreement with Castle Creek to develop and commercialize FCX-007 for the treatment of recessive dystrophic epidermolysis bullosa (RDEB).
read more
LabCorp’s Covance Drug Development segment will acquire Envigo’s nonclinical research services business and Envigo’s Research Models Services business will acquire the Covance Research Products business.
read more
MS Pharma has entered into an agreement to acquire 100% of the outstanding shares in Genepharm, a European pharmaceutical company.
read more
HitGen announced it has achieved a milestone in its discovery alliance with Merck & Co. Inc., Kenilworth NJ.
read more
Paragon Bioservices announced it will be exploring the formation of a wide-ranging partnership in gene therapy manufacturing with Sarepta Therapeutics.
read more
Pulmatrix and Cipla announced their entry into a Definitive Agreement for the co-development and commercialization of Pulmazole™, an inhaled iSPERSE™ formulation of the anti-fungal drug itraconazole.
read more